Craig H. Mallinckrodt, PhD
- 11Articles
- 26.2KReads
- 2003–2009Active
- 37Collaborators
- 96Citations
About
Craig H. Mallinckrodt, PhD, has authored multiple articles published between 2003 and 2009 focusing on major depressive disorder (MDD), anxiety, anxiolytics, primary care, and somatoform disorders. His work extensively explores the clinical use of duloxetine, including dosing strategies, safety, tolerability, and its effects on both emotional and physical symptoms of depression. Mallinckrodt has also investigated treatment onset, sexual functioning, and the impact of somatic symptoms on functional outcomes in depression. He has frequently collaborated with co-authors such as John G. Watkin, Madelaine M. Wohlreich, and Michael J. Detke.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
